An agreement between attorneys general and major drug distributors increased scrutiny on medications for A.D.H.D., addiction, anxiety and pain.
NYT > Health
Related Posts
Supercomputing redesign of a COVID monoclonal antibody
One of the monoclonal antibodies in the therapeutic Evusheld has been computationally redesigned to restore its action against Omicron variants of the virus that causes COVID-19. The computational redesign approach, combined with experimental validation, could…
New York Passes Bill to Shield Abortion Providers Sending Pills to States With Bans
The measure is one of several recently enacted by states aiming to expand access to medication abortion for patients who live where it is outlawed. NYT > Health
CVS and Walgreens Near $10 Billion Deal to Settle Opioid Cases
The dual agreements would resolve thousands of lawsuits over the retailers’ role in the addiction crisis. But a large majority of state, local and tribal governments must sign on. NYT > Health